STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income
Beginning Balance at Dec. 31, 2023	$ 224,088	$ 6	$ 658,751	$ (434,927)	$ 258
Beginning Balance (in shares) at Dec. 31, 2023		54,865,553
Issuance of common stock and pre-funded warrants, net	124,832	$ 1	124,831
Issuance of common stock, net (in shares)		12,500,000
Exercise of Pre-Funded Warrants ( in Shares)		2,857,104
Exercise of common stock options	631		631
Exercise of common stock options (in shares)		152,211
Issuance of common stock upon vesting of restricted stock units (In Shares)		306,850
Issuance of common stock under the Employee Stock Purchase Plan	1,084		1,084
Issuance of common stock under the Employee Stock Purchase Plan (In Shares)		340,137
Stock-based compensation expense	20,213		20,213
Unrealized gain on investments	121				121
Net loss	(127,847)			(127,847)
Ending Balance at Dec. 31, 2024	$ 243,122	$ 7	805,510	(562,774)	379
Ending Balance (in shares) at Dec. 31, 2024	71,021,855	71,021,855
Issuance of common stock and pre-funded warrants, net	$ 241,972	$ 3	241,969
Issuance of common stock, net (in shares)		25,910,345
Exercise of Pre-Funded Warrants ( in Shares)		636,887
Exercise of common stock options	$ 1,979	$ 1	1,978
Exercise of common stock options (in shares)	390,055	390,055
Issuance of common stock upon vesting of restricted stock units (In Shares)		395,252
Issuance of common stock under the Employee Stock Purchase Plan	$ 1,313		1,313
Issuance of common stock under the Employee Stock Purchase Plan (In Shares)		174,555
Stock-based compensation expense	25,037		25,037
Unrealized gain on investments	407				407
Net loss	(129,468)			(129,468)
Ending Balance at Dec. 31, 2025	$ 384,362	$ 11	$ 1,075,807	$ (692,242)	$ 786
Ending Balance (in shares) at Dec. 31, 2025	98,528,949	98,528,949